ACRUX Ltd
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally. The company provides estradiol transdermal sprays to women for the treatment of flushes associated with menopause under the Evamist and Lenzetto brand names; Dapsone 5% and Dapsone 7.5%, which are gels for th… Read more
ACRUX Ltd (ACR) - Total Assets
Latest total assets as of June 2025: AU$7.22 Million AUD
Based on the latest financial reports, ACRUX Ltd (ACR) holds total assets worth AU$7.22 Million AUD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
ACRUX Ltd - Total Assets Trend (2001–2025)
This chart illustrates how ACRUX Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
ACRUX Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
ACRUX Ltd's total assets of AU$7.22 Million consist of 66.5% current assets and 33.5% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 11.9% |
| Accounts Receivable | AU$3.79 Million | 52.5% |
| Inventory | AU$0.00 | 0.0% |
| Property, Plant & Equipment | AU$1.86 Million | 25.7% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2001–2025)
This chart illustrates how ACRUX Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ACRUX Ltd's current assets represent 66.5% of total assets in 2025, an increase from 0.0% in 2001.
- Cash Position: Cash and equivalents constituted 11.9% of total assets in 2025, down from 96.4% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2001.
- Asset Diversification: The largest asset category is accounts receivable at 52.5% of total assets.
ACRUX Ltd Competitors by Total Assets
Key competitors of ACRUX Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $110.50 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
ACRUX Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - ACRUX Ltd generates 0.16x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - ACRUX Ltd is currently not profitable relative to its asset base.
ACRUX Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.07 | 1.61 | 4.63 |
| Quick Ratio | 1.07 | 1.57 | 4.63 |
| Cash Ratio | 0.19 | 0.79 | 3.45 |
| Working Capital | AU$323.00K | AU$ 2.26 Million | AU$ 9.68 Million |
ACRUX Ltd - Advanced Valuation Insights
This section examines the relationship between ACRUX Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.62 |
| Latest Market Cap to Assets Ratio | 0.30 |
| Asset Growth Rate (YoY) | -19.4% |
| Total Assets | AU$7.22 Million |
| Market Capitalization | $2.16 Million USD |
Valuation Analysis
Below Book Valuation: The market values ACRUX Ltd's assets below their book value (0.30 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: ACRUX Ltd's assets decreased by 19.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for ACRUX Ltd (2001–2025)
The table below shows the annual total assets of ACRUX Ltd from 2001 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$7.22 Million | -19.39% |
| 2024-06-30 | AU$8.96 Million | -37.32% |
| 2023-06-30 | AU$14.30 Million | -6.38% |
| 2022-06-30 | AU$15.27 Million | -36.89% |
| 2021-06-30 | AU$24.20 Million | +30.67% |
| 2020-06-30 | AU$18.52 Million | -24.20% |
| 2019-06-30 | AU$24.43 Million | -24.80% |
| 2018-06-30 | AU$32.49 Million | -31.32% |
| 2017-06-30 | AU$47.31 Million | -11.36% |
| 2016-06-30 | AU$53.37 Million | +10.05% |
| 2015-06-30 | AU$48.49 Million | -8.88% |
| 2014-06-30 | AU$53.22 Million | +0.62% |
| 2013-06-30 | AU$52.90 Million | -9.58% |
| 2012-06-30 | AU$58.50 Million | -0.84% |
| 2011-06-30 | AU$58.99 Million | -29.44% |
| 2010-06-30 | AU$83.61 Million | +139.21% |
| 2009-06-30 | AU$34.95 Million | -15.31% |
| 2008-06-30 | AU$41.27 Million | +102.60% |
| 2007-06-30 | AU$20.37 Million | -12.33% |
| 2006-06-30 | AU$23.23 Million | -25.28% |
| 2005-06-30 | AU$31.09 Million | +218.66% |
| 2004-06-30 | AU$9.76 Million | -24.04% |
| 2003-06-30 | AU$12.85 Million | -30.02% |
| 2002-06-30 | AU$18.36 Million | +52.72% |
| 2001-06-30 | AU$12.02 Million | -- |